NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-200-1990-3-PT-24 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof PT EP 96907061.4 Expired
NCI E-200-1990-3-IT-19 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof IT EP 96907061.4 Expired
NCI E-200-1990-3-GR-17 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof GR EP 96907061.4 Expired
NCI E-200-1990-3-IE-18 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof IE EP 96907061.4 Expired
NCI E-200-1990-3-FI-14 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof FI EP 96907061.4 Abandoned
NCI E-200-1990-3-DE-11 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof DE EP 96907061.4 Expired
NCI E-200-1990-3-FR-15 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof FR EP 96907061.4 Expired
NCI E-200-1990-3-EP-03 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof EP National Stage 96907061.4 Expired
NCI E-200-1990-3-JP-07 GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR CARCINOMA SELF-ASSOCIATED ANTIGENS AND USES THEREOF JP National Stage 1996-525765 Expired
NCI E-200-1990-3-AU-04 Generation of Human Cytotoxic T-Cells Specific for Carcinoma Self Associated Antigens and Uses Thereof AU National Stage 50240/96 Expired
NCI E-200-1990-3-PCT-02 GENERATION OF HUMAN CYTOTOXIC T-CELLS SPECIFIC FOR CARCINOMA SELF-ASSOCIATED ANTIGENS AND USES THEREOF PCT PCT PCT/US1996/002156 Expired
NCI E-265-1994-0-JP-06 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE - INT6 JP National Stage 1996-524481 Abandoned
NCI E-265-1994-0-FR-10 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... FR EP 96907047.3 Abandoned
NCI E-265-1994-0-DE-03 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... DE EP 96907047.3 Abandoned
NCI E-265-1994-0-GB-05 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... GB EP 96907047.3 Abandoned
NCI E-265-1994-0-CH-09 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... CH EP 96907047.3 Abandoned
NCI E-265-1994-0-EP-04 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... EP National Stage 96907047.3 Abandoned
NCI E-265-1994-0-AU-07 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE, INT6, AND THE USE OF REAGENTS DERIVED FROM THESE SEQUENCES IN DIAGNOSTIC... AU National Stage 50230/96 Abandoned
NCI E-219-1995-0-US-01 Human Cancer Antigen of Tyrosinase-Related Protein 1 and 2 and Genes Encoding Same US ORD 08/599,602 5840839 Expired PDF
NCI E-265-1994-0-PCT-02 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE INT6 PCT PCT PCT/US1996/001884 Expired
NCI E-035-1995-0-US-01 RESTRICTION DISPLAY (RD-PCR) OF DIFFERNTIALLY EXPRESSED mRNAs US 60/011,379 Abandoned
NCI E-265-1994-0-CA-08 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF A NEW TUMOR GENE INT6 CA National Stage 2212573 Abandoned
NCI E-040-1996-0-US-01 METHODS AND COMPOSITIONS FOR TRANSFORMING DENDRITIC CELLS AND ACTIVATING T CELLS US 60/011,433 Abandoned
NCI E-136-1990-0-US-22 TREATED BIRDSEED PREFERENTIALLY PALATABLE TO BIRDS BUT NOT TO ANIMALS HAVING CAPSAICIN SENSITIVE RECEPTORS US DIV 08/596,807 5672354 Expired PDF
NCI E-084-1990-1-US-01 Complexes Of Nitric Oxide With Polyamines US CIP 08/522,405 5683668 Abandoned PDF
NCI E-053-1996-0-US-01 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL CULTURES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTATE CANCER US 60/011,042 Abandoned
NCI E-296-2005-0-CA-03 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent CA National Stage 2129813 Expired
NCI E-296-2005-0-GB-05 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent GB EP 94112509.8 Expired
NCI E-296-2005-0-FR-07 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent FR EP 94112509.8 Expired
NCI E-296-2005-0-DE-06 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent DE EP 94112509.8 Expired
NCI E-296-2005-0-IT-09 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent IT EP 94112509.8 Expired
NCI E-296-2005-0-ES-08 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent ES EP 94112509.8 Expired
NCI E-296-2005-0-EP-04 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent EP National Stage 94112509.8 Expired
NCI E-296-2005-0-PCT-02 5-Aminoflavone Derivatives PCT PCT PCT/JP1996/000181 Expired
NIAID E-017-1996-0-US-01 CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION US 60/010,854 Abandoned
NIMH E-110-1993-0-US-10 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CON 08/593,269 5688501 Abandoned PDF
NIDDK E-225-1995-0-US-01 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. US 60/010,737 Abandoned
NCI E-036-1997-0-US-01 PEPTIDE ANTIGENS FOR IMMUNOTHERAPEUTIC TREATMENT AND/OR PREVENTION OF HIV US 60/010,560 Abandoned
NCI E-054-1992-1-US-02 Method For Measuring Incident Light in a Body Cavity US DIV 08/592,440 5730700 Expired PDF
NCI E-052-1995-0-PCT-02 Method for isolating Dendritic Cells PCT PCT PCT/US1996/001090 Expired
NEI E-199-1995-0-US-01 HYDROXYLAMINE COMPOSITIONS FOR THE PREVENTION OR RETARDATION OF CATARACTS US 60/010,637 Abandoned
NIAID E-519-1985-0-JP-13 Protective Synthetic Peptide Against Malaria And Encoding Gene JP National Stage 1996-011280 Abandoned
NCI E-062-1995-2-JP-02 IMMUNOTOXIN-MEDIATED CONDITIONAL DISRUPTION OF SPECIFIC NEURONS IN TRANSGENIC MICE JP National Stage 1996-023316 Abandoned
OD E-999-2001-0-US-01 Primate Embryonic Stem Cells US ORD 08/591,246 5843780 Expired PDF
NINDS E-106-1995-0-PCT-02 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY PCT PCT PCT/US1996/000555 Expired
NCI E-137-1995-0-PCT-02 IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS PCT PCT PCT/US1996/000547 Expired
NINDS E-106-1995-0-JP-07 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY JP National Stage 1996-522349 Abandoned
NINDS E-106-1995-0-EP-06 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY EP National Stage 96904466.8 Abandoned
NINDS E-106-1995-0-AU-05 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY AU National Stage 48566/96 Abandoned
NCI E-057-1994-1-EP-05 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS EP National Stage 96903473.5 Abandoned